Nonprofit hospitals often get overshadowed at the J.P. Morgan Healthcare Conference, the health care industry’s swankiest investor meeting whose agenda is dominated by drugmakers and biotech companies.
But hospitals are still the largest part of America’s health care economy, commanding nearly a third of the country’s $4.7 billion health care tab. And similar to last year, when hospitals touted their plans for expansion and hiking prices, they will have a rosy picture to sell to financiers as patients flock to their facilities.
STAT spoke with attorneys, analysts, and health care executives who are attending JPM’s event or are watching from afar. Even though some of the health systems presenting at the conference just lost hundreds of millions in 2023, expect a theme of cautious optimism for the coming year from hospitals, medical groups, health insurers, and the vendors who serve them. Each of these sectors is dealing with its own challenges — namely, high labor costs and a tighter regulatory environment — but that’s not likely to be emphasized in their presentations to investors. Instead, they’ll outline their plans for emerging stronger.
This article is exclusive to STAT+ subscribers
Unlock this article — plus daily market-moving biopharma analysis — by subscribing to STAT+.
Already have an account? Log in
Already have an account? Log in
To submit a correction request, please visit our Contact Us page.
STAT encourages you to share your voice. We welcome your commentary, criticism, and expertise on our subscriber-only platform, STAT+ Connect